Author:
Niu Hongxia,Gu Jiaying,Zhang Ying
Abstract
AbstractPersisters refer to genetically drug susceptible quiescent (non-growing or slow growing) bacteria that survive in stress environments such as antibiotic exposure, acidic and starvation conditions. These cells can regrow after stress removal and remain susceptible to the same stress. Persisters are underlying the problems of treating chronic and persistent infections and relapse infections after treatment, drug resistance development, and biofilm infections, and pose significant challenges for effective treatments. Understanding the characteristics and the exact mechanisms of persister formation, especially the key molecules that affect the formation and survival of the persisters is critical to more effective treatment of chronic and persistent infections. Currently, genes related to persister formation and survival are being discovered and confirmed, but the mechanisms by which bacteria form persisters are very complex, and there are still many unanswered questions. This article comprehensively summarizes the historical background of bacterial persisters, details their complex characteristics and their relationship with antibiotic tolerant and resistant bacteria, systematically elucidates the interplay between various bacterial biological processes and the formation of persister cells, as well as consolidates the diverse anti-persister compounds and treatments. We hope to provide theoretical background for in-depth research on mechanisms of persisters and suggest new ideas for choosing strategies for more effective treatment of persistent infections.
Publisher
Springer Science and Business Media LLC
Reference501 articles.
1. Cook, M. A. & Wright, G. D. The past, present, and future of antibiotics. Sci. Transl. Med. 14, eabo7793 (2022).
2. Hutchings, M. I., Truman, A. W. & Wilkinson, B. Antibiotics: past, present and future. Curr. Opin. Microbiol. 51, 72–80 (2019).
3. Khardori, N. Antibiotics–past, present, and future. Med. Clin. North Am. 90, 1049–1076 (2006).
4. Ferrara, F. et al. Antibacterial agents and the fight against antibiotic resistance: a real-world evidence analysis of consumption and spending by an Italian healthcare company. Ann. Pharm. Fr. 82, 545–552 (2024).
5. Klingeberg, A. et al. The percentage of antibiotic resistance in uncomplicated community-acquired urinary tract infections-findings of the RedAres project. Dtsch Arztebl Int 121, 175–181 (2024).
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献